Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access
Beate Bittner, Johannes Schmidt
BioDrugs (2023) Vol. 38, Iss. 1, pp. 23-46
Open Access | Times Cited: 10

Showing 10 citing articles:

Subcutaneous delivery of immune checkpoint inhibitors: new route replacing intravenous administration?
Yusuke Inoue
Translational Lung Cancer Research (2024) Vol. 13, Iss. 4, pp. 947-951
Open Access | Times Cited: 4
An industry perspective on hyaluronidase co-formulated biopharmaceutics
Jeremy Guo, Jingwen Weng, Fangyuan Zhou, et al.
Journal of Controlled Release (2025)
Closed Access
Comprehensive overview of antibody drug-related clinical studies in gynecology: insights from ClinicalTrials.gov
Xiaoling Zhou, Xiaotian Li, 凡平 高瀬, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma
Hang Quach, Gurdeep Parmar, María‐Victoria Mateos, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 6, pp. 358-363
Closed Access | Times Cited: 1
Injectable hydrogel formulations: Design, synthesis and applications for subcutaneous delivery – A comprehensive review
Sruthi Sarvepalli, Hari P. Kandagatla
European Polymer Journal (2024), pp. 113610-113610
Closed Access | Times Cited: 1
Reversible Protein Complexes: Advancing Subcutaneous Delivery with Controlled and Sustained Release of High Concentration Biologics
Pierre-Louis Destruel, Vanessa Braun, Vanessa Lebouc, et al.
(2024)
Closed Access
Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations
Arjun Gupta, Michelle Tregear, Makala B. Pace, et al.
JCO Oncology Practice (2024)
Closed Access
Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity
Leda Coelewij, Marsilio Adriani, Pierre Dönnes, et al.
Clinical Immunology (2024) Vol. 267, pp. 110339-110339
Open Access
Reversible protein complexes: advancing subcutaneous delivery with controlled and sustained release of high concentration biologics
Vanessa Braun, Vanessa Lebouc, G. Schwach, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106122-106122
Closed Access
Acknowledgement to Referees

BioDrugs (2024)
Closed Access
Page 1

Scroll to top